홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Pyrazine-2-Carboxylic Acid Hydrazide → HCID 66599317, 화합물

HRID 1889077
인쇄

반응식

HRID 1889077 반응식
[Cl:1][C:2]1[CH:7]=[C:6]([F:8])[CH:5]=[CH:4][C:3]=1[C:9]([N:11]1[CH2:16][CH2:15][NH:14][C:13](=O)[CH2:12]1)=[O:10].F[B-](F)(F)F.C([O+](CC)CC)C.[N:30]1[CH:35]=[CH:34][N:33]=[CH:32][C:31]=1[C:36]([NH:38][NH2:39])=O>ClCCl>[Cl:1][C:2]1[CH:7]=[C:6]([F:8])[CH:5]=[CH:4][C:3]=1[C:9]([N:11]1[CH2:16][CH2:15][N:14]2[C:36]([C:31]3[CH:32]=[N:33][CH:34]=[CH:35][N:30]=3)=[N:38][N:39]=[C:13]2[CH2:12]1)=[O:10]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

5

반응물 3

HCID 258796Pyrazine-2-Carboxylic Acid HydrazideHCID 2723982Triethyloxonium tetrafluoroborateHCID 255371164-(2-Chloro-4-fluorobenzoyl)piperazin-2-one

생성물 1

HCID 66599317HCID 66599317, 화합물

시약·촉매·용매 1

HCID 6344Dichloromethane용매

실험 절차

To a suspension of 4-[(2-chloro-4-fluorophenyl)carbonyl]-2-piperazinone (I3)(0.78 g, 3.04 mmol) in Dichloromethane (DCM) (7.60 ml) was added triethyloxonium tetrafluoroborate (0.606 g, 3.19 mmol) and the mixture was stirred at room temperature under argon. After 5-10 minutes it turned to a yellow solution. TLC showed the formation of the imidate (some unreacted starting material always present due to instability of imidate on TLC). After 1 hour 2-pyrazinecarbohydrazide (0.504 g, 3.65 mmol, commercially available) was added but it was insoluble. After 15 minutes the solvent was evaporated in vacuo and the residue taken in n-butanol (7.60 ml) and heated at reflux (120° C.). After 2 hours LCMS showed a main peak which is consistent with the desired product. It was concentrated in vacuo and the residue was purified by flash chromatography (Biotage SP4, 40+M cartridge) with a gradient of 2M ammonia in MeOH 0 to 10% in DCM. The crude product was then dissolved in EtOAc (50 mL), the precipitate filtered off (50 mg of impurity by LCMS) and the solution washed with sat. NH4Cl (30 mL), water (30 mL) and brine (30 mL) and finally dried over MgSO4 to afford an off-white solid that was fruther purified by MDAP to isolate the desired product in 310 mg as a white solid.

후처리

  1. additioncommercially available) was added
  2. customAfter 15 minutes the solvent was evaporated in vacuo
  3. temperatureheated
  4. temperatureat reflux (120° C.)
  5. waitAfter 2 hours LCMS showed
  6. concentrationIt was concentrated in vacuo
  7. customthe residue was purified by flash chromatography (Biotage SP4, 40+M cartridge) with a gradient of 2M ammonia in MeOH 0 to 10% in DCM
  8. dissolutionThe crude product was then dissolved in EtOAc (50 mL)
  9. filtrationthe precipitate filtered off (50 mg of impurity by LCMS)
  10. washthe solution washed with sat. NH4Cl (30 mL), water (30 mL) and brine (30 mL)
  11. dry with materialfinally dried over MgSO4
  12. customto afford an off-white solid
  13. customthat was fruther purified by MDAP

출처 및 근거

ORD 기록
ord-82b5d4bf2ac54375a725345f49f373a6
출처 데이터셋
uspto-grants-2013_08
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08501946B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트